AFT Pharmaceuticals Limited Stock price

Equities

AFT

NZAFTE0001S4

Pharmaceuticals

End-of-day quote New Zealand S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
3.13 NZD +2.62% Intraday chart for AFT Pharmaceuticals Limited +5.39% -10.57%
Sales 2024 * 193M 115M Sales 2025 * 220M 132M Capitalization 328M 196M
Net income 2024 * 15M 8.96M Net income 2025 * 17M 10.15M EV / Sales 2024 * 1.85 x
Net Debt 2024 * 28.28M 16.89M Net Debt 2025 * 26.88M 16.05M EV / Sales 2025 * 1.61 x
P/E ratio 2024 *
21.6 x
P/E ratio 2025 *
18.9 x
Employees 100
Yield 2024 *
0.52%
Yield 2025 *
0.73%
Free-Float 25.53%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.62%
1 week+5.39%
Current month-3.99%
1 month-4.86%
3 months-9.01%
6 months-7.94%
Current year-10.57%
More quotes
1 week
2.85
Extreme 2.85
3.13
1 month
2.84
Extreme 2.84
3.28
Current year
2.84
Extreme 2.84
3.85
1 year
2.84
Extreme 2.84
3.92
3 years
2.84
Extreme 2.84
5.01
5 years
1.70
Extreme 1.7
5.65
10 years
1.70
Extreme 1.7
5.65
More quotes
Managers TitleAgeSince
Founder - 97-09-03
Founder - 97-09-03
Director of Finance/CFO - 97-09-03
Members of the board TitleAgeSince
Director/Board Member 67 20-12-22
Chairman - 15-06-21
Founder - 97-09-03
More insiders
Date Price Change Volume
24-03-28 3.13 +2.62% 3,317
24-03-27 3.05 0.00% 12,538
24-03-26 3.05 +0.66% 32,691
24-03-25 3.03 +2.71% 27,037
24-03-22 2.95 +3.87% 115,001

End-of-day quote New Zealand S.E., March 27, 2024

More quotes
AFT Pharmaceuticals Limited is a New Zealand-based multinational pharmaceutical company. The Company develops, markets and distributes a portfolio of pharmaceutical products across a range of therapeutic categories, which are distributed across three pharmaceutical distribution channels: over-the-counter (OTC), prescription and hospital. Its product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs. The Company develops and in-licenses products for sale by its own dedicated sales teams in Australia and New Zealand and in certain Southeast Asian markets, and out-licenses its products to local licensees and distributors in the rest of the world. A-Scabies, Allersoothe, Allersoothe Elixir, BecloClear, Bites, Calci-Tab, Candacort, Candacort Minipak, Candaderm, Coco-Scalp, Combolieve, Cromo-Fresh, Dry skin, Eczema, Emulsifying Ointment BP, Fenpaed, Fenpaed Double Strength, Ferro-Sachets, HYLO-FORTE and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.13 NZD
Average target price
3.7 NZD
Spread / Average Target
+18.21%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock AFT Pharmaceuticals Limited - New Zealand S.E.